Business

Purdue Pharma co-owner Jonathan Sackler dead at 65

By Spencer Neale
Published July 6, 2020 8:42pm ET
Add Washington Examiner on Google
Purdue Pharma co-owner Jonathan Sackler dead at 65
OxyContin is Purdue's No.1 drug, although sales have decreased recently due to generics. (AP Photo/Douglas Healey). | Douglas Healey

Purdue Pharma, the maker of Oxycontin, announced through a court filing that co-owner Jonathan Sackler has died from cancer.

Jonathan Sackler, the son of Raymond Sackler, who bought Purdue Frederick in 1952, was an executive board member and oversaw the company’s name change to Purdue Pharma. He died last week, the company confirmed on Monday.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Health Pharmaceutical Industry